Impacting Policy and Payment
Anand Shah, MD, MPH, conducted the study titled "Economic Evaluation of SBRT versus Surgery for Stage I NSCLC."
In this ROI-funded grant, Dr. Shah:
- Developed novel episode-based Medicare payment definitions for SBRT in early stage lung cancer.
- Modeled an advanced APM and evaluated value in academic and non-academic care settings.
- Gained methodological expertise that can be used in future efforts to formulate value-based, integrated oncology advanced APMs.
Dr. Shah is Deputy Commissioner for Medical and Scientific Affairs at the Food and Drug Administration and previously served in two senior leadership roles at the Centers for Medicare & Medicaid Services (CMS).